NFKB1 and glaucoma: Although preclinical studies support the contribution of inflammatory processes as an important component of neurodegeneration in glaucoma and point to NF-κB the main transcriptional activator of glia-driven neuroinflammation and secondary injury processes, clinical modulation of NF-κB may be complicated.